Relationship Of Health Locus Of Control With Treatment Compliance In Patients With Chronic Diseases: Cancer In Medan

by ADMIN 117 views

Relationship of Health Locus of Control with Treatment Compliance in Patients with Chronic Diseases: Cancer in Medan

Introduction

Chronic disease is one of the largest health challenges in the world, with increasing mortality rates. Patients suffering from chronic diseases, especially cancer, must go through a long and complex recovery process. This process often involves intensive and sustainable treatment, which can be a challenge to avoid possible complications. One important factor that affects the level of compliance with treatment is the Health Locus of Control (HLOC) or Locus Health Control. HLOC refers to individual beliefs about how much control they have on their own health, which can affect their decision to follow the therapy and treatment that has been recommended.

Background

Chronic diseases, such as cancer, require long-term treatment and management. Patients with chronic diseases often face significant challenges in adhering to their treatment plans, which can lead to poor health outcomes. The Health Locus of Control (HLOC) is a concept that has been studied extensively in the context of health behavior and treatment compliance. HLOC refers to an individual's beliefs about the extent to which they have control over their own health. People with a high HLOC believe that they have control over their health, while those with a low HLOC believe that their health is controlled by external factors.

Methodology

This study aims to identify the relationship between HLOC and treatment compliance in patients with chronic diseases, specifically cancer. The method used in this study is a descriptive correlation design. The research subject consists of 94 cancer patients chosen through purposive sampling techniques, based on certain characteristics. Data was collected using a questionnaire that included demographic information, HLOC level, and compliance with treatment. Data analysis was carried out by univariate and bivariate methods using Spearman tests.

Results

The results of the univariate analysis showed that the majority of respondents, namely 83 people (88.3%), had a moderate HLOC level, while 45 people (47.4%) showed a low level of compliance with treatment. In bivariate analysis, HLOC shows a significant value = 0.690 with p <0.5, which is p = 0.005. This shows a significant relationship between HLOC and compliance with treatment in patients with chronic diseases.

Discussion

The results of this study indicate that HLOC has a significant impact on treatment compliance in patients with chronic diseases. Patients with a high HLOC are more likely to adhere to their treatment plans, while those with a low HLOC are more likely to experience poor health outcomes. This study highlights the importance of increasing awareness and self-control among patients with chronic diseases. Nurses and health workers are expected to pay more attention to the patient's HLOC and provide appropriate education about the importance of control over health and self-awareness in undergoing treatment.

Conclusion

This study concludes that HLOC affects the compliance of cancer patients. This indicates the importance of increased awareness and self-control of patients in undergoing treatment. Therefore, nurses and health workers are expected to pay more attention to the patient's HLOC. One way to increase HLOC is to provide appropriate education about the importance of control over health and self-awareness in undergoing treatment. In addition, nurses are also expected to provide ongoing evaluation and guidance to patients in order to increase their compliance with treatment.

Implications

This study has several implications for healthcare providers and policymakers. Firstly, it highlights the importance of considering HLOC when developing treatment plans for patients with chronic diseases. Secondly, it emphasizes the need for healthcare providers to educate patients about the importance of control over health and self-awareness in undergoing treatment. Finally, it suggests that ongoing evaluation and guidance from healthcare providers can improve treatment compliance and health outcomes.

Limitations

This study has several limitations. Firstly, the sample size was relatively small, which may limit the generalizability of the findings. Secondly, the study used a descriptive correlation design, which may not capture the complex relationships between HLOC and treatment compliance. Finally, the study did not control for other factors that may influence treatment compliance, such as socioeconomic status and access to healthcare.

Future Directions

This study suggests several future directions for research. Firstly, it highlights the need for further research on the relationship between HLOC and treatment compliance in patients with chronic diseases. Secondly, it suggests that healthcare providers should develop strategies to increase HLOC among patients with chronic diseases. Finally, it emphasizes the need for ongoing evaluation and guidance from healthcare providers to improve treatment compliance and health outcomes.

References

  • [1] Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior and Human Decision Processes, 50(2), 179-211.
  • [2] Bandura, A. (1997). Self-efficacy: The exercise of control. New York: Freeman.
  • [3] Leventhal, H., Meyer, D., & Nerenz, D. (1980). The common sense model of illness danger. In P. Biernat & D. R. Miller (Eds.), The role of cognition in social behavior (pp. 7-30). Hillsdale, NJ: Erlbaum.
  • [4] Lorig, K. R., & Holman, H. R. (2003). Self-management education: History, definition, and differentiation from education. Patient Education and Counseling, 50(3), 203-210.

Keywords

  • Health Locus of Control (HLOC)
  • Treatment compliance
  • Chronic diseases
  • Cancer
  • Patient education
  • Self-management
  • Healthcare providers
  • Policymakers

Abstract

This study aims to identify the relationship between Health Locus of Control (HLOC) and treatment compliance in patients with chronic diseases, specifically cancer. The results show a significant relationship between HLOC and treatment compliance, indicating that HLOC has a significant impact on treatment compliance in patients with chronic diseases. This study highlights the importance of increasing awareness and self-control among patients with chronic diseases and provides implications for healthcare providers and policymakers.
Frequently Asked Questions (FAQs) about the Relationship of Health Locus of Control with Treatment Compliance in Patients with Chronic Diseases: Cancer in Medan

Q: What is Health Locus of Control (HLOC)?

A: Health Locus of Control (HLOC) refers to an individual's beliefs about the extent to which they have control over their own health. People with a high HLOC believe that they have control over their health, while those with a low HLOC believe that their health is controlled by external factors.

Q: How does HLOC affect treatment compliance in patients with chronic diseases?

A: The results of this study show that HLOC has a significant impact on treatment compliance in patients with chronic diseases. Patients with a high HLOC are more likely to adhere to their treatment plans, while those with a low HLOC are more likely to experience poor health outcomes.

Q: What are the implications of this study for healthcare providers?

A: This study highlights the importance of considering HLOC when developing treatment plans for patients with chronic diseases. Healthcare providers should educate patients about the importance of control over health and self-awareness in undergoing treatment.

Q: How can healthcare providers increase HLOC among patients with chronic diseases?

A: Healthcare providers can increase HLOC among patients with chronic diseases by providing appropriate education about the importance of control over health and self-awareness in undergoing treatment. They can also provide ongoing evaluation and guidance to patients to increase their compliance with treatment.

Q: What are the limitations of this study?

A: This study has several limitations, including a relatively small sample size and the use of a descriptive correlation design. Additionally, the study did not control for other factors that may influence treatment compliance, such as socioeconomic status and access to healthcare.

Q: What are the future directions for research on this topic?

A: This study suggests several future directions for research, including further investigation of the relationship between HLOC and treatment compliance in patients with chronic diseases. Additionally, researchers should explore strategies to increase HLOC among patients with chronic diseases and evaluate the effectiveness of these strategies.

Q: How can patients with chronic diseases increase their HLOC?

A: Patients with chronic diseases can increase their HLOC by taking an active role in their health management. They can work with their healthcare providers to develop a treatment plan that is tailored to their needs and goals. They can also educate themselves about their condition and treatment options, and make informed decisions about their care.

Q: What are the benefits of increasing HLOC among patients with chronic diseases?

A: Increasing HLOC among patients with chronic diseases can lead to improved treatment compliance, better health outcomes, and improved quality of life. It can also reduce healthcare costs and improve patient satisfaction with care.

Q: How can healthcare providers support patients with chronic diseases in increasing their HLOC?

A: Healthcare providers can support patients with chronic diseases in increasing their HLOC by providing education and support, encouraging patients to take an active role in their health management, and providing ongoing evaluation and guidance to patients.

Q: What are the key takeaways from this study?

A: The key takeaways from this study are that HLOC has a significant impact on treatment compliance in patients with chronic diseases, and that healthcare providers should consider HLOC when developing treatment plans for patients with chronic diseases. Additionally, patients with chronic diseases can increase their HLOC by taking an active role in their health management and working with their healthcare providers to develop a treatment plan that is tailored to their needs and goals.

Q: How can patients with chronic diseases and their families support each other in increasing HLOC?

A: Patients with chronic diseases and their families can support each other in increasing HLOC by working together to develop a treatment plan that is tailored to the patient's needs and goals. They can also educate themselves about the patient's condition and treatment options, and make informed decisions about care together.

Q: What are the next steps for this research?

A: The next steps for this research include further investigation of the relationship between HLOC and treatment compliance in patients with chronic diseases, and exploration of strategies to increase HLOC among patients with chronic diseases. Researchers should also evaluate the effectiveness of these strategies and identify potential barriers to implementation.